ZA824622B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA824622B
ZA824622B ZA824622A ZA824622A ZA824622B ZA 824622 B ZA824622 B ZA 824622B ZA 824622 A ZA824622 A ZA 824622A ZA 824622 A ZA824622 A ZA 824622A ZA 824622 B ZA824622 B ZA 824622B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA824622A
Other languages
English (en)
Inventor
R Todd
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ZA824622B publication Critical patent/ZA824622B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA824622A 1981-07-10 1982-06-29 Pharmaceutical compositions ZA824622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8121315 1981-07-10

Publications (1)

Publication Number Publication Date
ZA824622B true ZA824622B (en) 1983-04-27

Family

ID=10523154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA824622A ZA824622B (en) 1981-07-10 1982-06-29 Pharmaceutical compositions

Country Status (5)

Country Link
EP (1) EP0069600A3 (xx)
JP (1) JPS5810519A (xx)
AU (1) AU8533582A (xx)
GB (1) GB2100985A (xx)
ZA (1) ZA824622B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JP2835741B2 (ja) * 1989-04-10 1998-12-14 コニカ株式会社 枚葉カード類の樹脂ラミネート方法
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
JPH07506839A (ja) * 1992-12-04 1995-07-27 メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド スプレー可能な鎮痛剤組成物およびその使用方法
US5552406A (en) * 1994-06-17 1996-09-03 The Mclean Hospital Corporation Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists
US6264974B1 (en) 1998-07-07 2001-07-24 Salvagnini Italia Spa Buccal and sublingual administration of physostigmine
DE69925158T2 (de) * 1998-12-18 2006-03-02 Palladin Healthcare International Ltd., Toronto Zusammensetzung zur behandlung von verbrennungen
DE19907328C2 (de) * 1999-02-20 2002-10-24 Johannes Reichardt Verfahren und System zur visuellen Programmierung
PT2561860T (pt) 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
ES2359977T3 (es) 2003-03-31 2011-05-30 Titan Pharmaceuticals, Inc. Dispositivo polimérico implantable para liberación sostenida de agonista de dopamina.
US20070116730A1 (en) * 2005-11-21 2007-05-24 Schering-Plough Animal Health Corp. Pharmaceutical compositions
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
GB2461681A (en) * 2008-04-17 2010-01-13 Pharmasol Ltd Buprenorphine liquid spray formulation with solvent and antioxidant
WO2010072398A2 (en) * 2008-12-22 2010-07-01 Boehringer Ingelheim Limited Veterinary formulations
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
GB2483579A (en) * 2010-06-30 2012-03-14 Londonpharma Ltd Sublingual formulations comprising methadone and ethanol for use in reducing pain
EP3939569A1 (en) 2011-09-19 2022-01-19 Orexo AB New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB2487007B (en) * 2012-03-19 2013-06-05 Londonpharma Ltd COC containers and delivery devices for the sublingual administration of opioids
JP7378391B2 (ja) * 2017-10-20 2023-11-13 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 有効成分としてオピオイド受容体アゴニストを含む医薬製剤、その製造方法および治療的使用
EP3743072B1 (en) * 2018-01-22 2023-10-25 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition for sustained release delivery of buprenorphine
BR112021019901A2 (pt) * 2019-04-18 2022-02-15 Chiesi Farm Spa Método para tratar síndrome de abstinência neonatal devido à retirada de opioides

Also Published As

Publication number Publication date
EP0069600A3 (en) 1984-04-04
AU8533582A (en) 1984-01-12
JPS5810519A (ja) 1983-01-21
GB2100985A (en) 1983-01-12
EP0069600A2 (en) 1983-01-12

Similar Documents

Publication Publication Date Title
PH25637A (en) Dipyridamole-containing pharmaceutical form
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
ZA824622B (en) Pharmaceutical compositions
NZ201520A (en) Substituted aminopyridazines and pharmaceutical compositions
ZA825397B (en) Pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
ZA822856B (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
ZA817684B (en) Pharmaceutical compositions
ZA826477B (en) Pharmaceutical compositions
ZA826479B (en) Pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
ZA82186B (en) Pharmaceutical compositions
GB8331068D0 (en) Pharmaceutical compositions